WVE-N531 demonstrated statistically significant improvements in muscle biopsy measures and functional measures in patients ...
13h
Clinical Trials Arena on MSNWave Life Sciences unveils Phase II data for DMD therapy, WVE-N531Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...
For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne muscular dystrophy, aging or other degenerative conditions, muscle loss can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results